Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China flag China · Delayed Price · Currency is CNY
9.61
+0.11 (1.16%)
Apr 10, 2026, 1:55 PM CST

SHE:300534 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
2,8822,8762,6392,9942,6914,465
Market Cap Growth
16.00%8.97%-11.85%11.27%-39.74%154.23%
Enterprise Value
2,8692,8952,5062,9422,6084,404
Last Close Price
9.509.488.679.788.7914.58
PE Ratio
65.5665.43102.2748.5769.37-
PS Ratio
3.253.242.542.773.3715.51
PB Ratio
3.693.683.634.213.056.09
P/TBV Ratio
4.604.594.515.373.576.81
P/FCF Ratio
--28.71-11.1288.04
P/OCF Ratio
--15.5131.0210.0687.32
EV/Sales Ratio
3.243.262.412.723.2615.30
EV/EBITDA Ratio
18.9819.3918.4826.3431.31332.41
EV/EBIT Ratio
27.1827.4225.5435.9646.31-
EV/FCF Ratio
-57.50-27.26-10.7886.84
Debt / Equity Ratio
0.200.200.150.20--
Debt / EBITDA Ratio
1.031.030.811.29--
Debt / FCF Ratio
--1.19---
Net Debt / Equity Ratio
-0.11-0.11-0.25-0.20-0.42-0.13
Net Debt / EBITDA Ratio
-0.57-0.57-1.33-1.29-4.43-7.48
Net Debt / FCF Ratio
1.701.70-1.964.84-1.53-1.95
Asset Turnover
0.630.630.760.810.750.34
Inventory Turnover
2.432.432.714.224.834.02
Quick Ratio
1.111.111.011.211.503.59
Current Ratio
1.431.431.301.481.794.52
Return on Equity (ROE)
8.66%8.66%7.21%10.52%6.02%-0.86%
Return on Assets (ROA)
4.72%4.72%4.48%3.85%3.29%-0.69%
Return on Invested Capital (ROIC)
12.10%13.67%8.82%11.54%7.22%-1.41%
Return on Capital Employed (ROCE)
11.30%11.30%11.10%9.10%6.20%-1.20%
Earnings Yield
1.53%1.53%0.98%2.06%1.44%-0.20%
FCF Yield
-1.73%-1.74%3.48%-1.00%9.00%1.14%
Dividend Yield
0.41%-0.46%0.21%--
Payout Ratio
33.75%33.75%59.27%6.19%1.28%-
Buyback Yield / Dilution
-0.01%-0.03%0.05%-0.05%0.10%0.54%
Total Shareholder Return
0.41%-0.03%0.51%0.16%0.10%0.54%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.